01 Symposium on Creative Approaches to Improving Medicines Globally
The second stakeholder discussions on the topic of access to medical products will take place in 2019. The event will focus on Creative Approaches to Improving Access to Medicines Globally – Ideas from the Hepatitis C Experience. The IPI is organising this symposium together with the Graduate Institute of International and Development Studies and the Federal Office of Public Health. The one-day event will take place on 3 December 2019 at the Graduate Institute in Geneva (Maison de la paix, Ivan Pictet Auditorium).
The aim is to discuss new ways of promoting innovation and improving access to medicines worldwide. Hepatitis C (Hep C) medicines will serve as a case study. Three panels of leading experts will examine different aspects of the issue – national strategies for HepC treatment, models for promoting innovation and new approaches to public health, as well as their impact on access to medicines and health policies.
Felix Addor will give an introductory lecture which will look at the history of access to hepatitis C medicines and the interaction between public and private research and development. One of the three panels will be moderated by an IPI employee.
You can find further information on the programme and registration on the website of the Global Health Centre (Graduate Institute of International and Development Studies). Links
Learn more about the tasks the IPI performs in balancing IP protection and public health. You can also read a retrospective report on the last stakeholder event of 1 February 2018.
02 IPI fax numbers to be discontinued from 1 January 2020
The IPI will discontinue its fax services at the end of 2019. The reason for this is that the IPI’s telecommunications provider is switching from analogue telephony to the Internet Protocol (known as All IP). As a result, faxes would be susceptible to errors and the complete transmission of messages and documents would not be guaranteed.
Email and post are offered as alternative means of submission. For Swiss and international trade mark applications, we recommend that applicants use the electronic application systems e-trademark and IR-Online.
It is also possible to send submissions by email. To be considered legally-binding and in observance of time limits, however, they must be sent to a specially designated email address. You can find further information on electronic submission on the IPI website.
Federal Institute of Intellectual Property
Deputy Director General